Mediators of Inflammation / 2020 / Article / Tab 1

Research Article

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy

Table 1

Demographic and clinical features of our cohort of 14 patients.

Demographic, laboratory, and clinical data
 Age (years)
 Age at scleritis onset (years)
 Disease duration (years)
 HLA ()HLA-B51 (4)
HLA-B27 (1)
HLA-B35 (1)
 Female/male ()8/6
Eye disease eyes
 Anterior diffuse scleritis11 (57.89%)
 Anterior nodular scleritis4 (21.05%)
 Anterior necrotizing scleritis1 (5.26%)
 Posterior scleritis3 (15.80%)
 Concomitant uveitis4 (4 AU)
 Associated keratitis3 PUK
Associated systemic disease 
 Rheumatoid arthritis7
 Granulomatosis with polyangiitis2
 Microscopic polyangiitis1
 Psoriatic arthritis1
 Familial Mediterranean fever1

AU: anterior uveitis; HLA: human leukocyte antigen; PUK: peripheral ulcerative keratitis; SD: standard deviation.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.